BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9250313)

  • 1. pCEA canalicular immunostaining in fine needle aspiration biopsy diagnosis of hepatocellular carcinoma.
    Wee A; Nilsson B
    Acta Cytol; 1997; 41(4):1147-55. PubMed ID: 9250313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyclonal carcinoembryonic antigen staining in the cytologic differential diagnosis of primary and metastatic hepatic malignancies.
    Wolber RA; Greene CA; Dupuis BA
    Acta Cytol; 1991; 35(2):215-20. PubMed ID: 1709323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor.
    Yoder M; Zimmerman RL; Bibbo M
    Anal Quant Cytol Histol; 2004 Apr; 26(2):61-4. PubMed ID: 15131892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of polyclonal and monoclonal antibodies against carcinoembryonic antigen in hepatic fine-needle aspirates.
    Rishi M; Kovatich A; Ehya H
    Diagn Cytopathol; 1994 Dec; 11(4):358-61; discussion 361-2. PubMed ID: 7895575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
    Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver.
    Ma CK; Zarbo RJ; Frierson HF; Lee MW
    Am J Clin Pathol; 1993 May; 99(5):551-7. PubMed ID: 7684185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
    Wang L; Vuolo M; Suhrland MJ; Schlesinger K
    Acta Cytol; 2006; 50(3):257-62. PubMed ID: 16780018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma.
    Christensen WN; Boitnott JK; Kuhajda FP
    Mod Pathol; 1989 Jan; 2(1):8-12. PubMed ID: 2466290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F; Abdallah H; Meschter S
    Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical localization of polyclonal carcinoembryonic antigen in hepatocellular carcinomas.
    Carrozza MJ; Calafati SA; Edmonds PR
    Acta Cytol; 1991; 35(2):221-4. PubMed ID: 1851357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL
    Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of clusterin immunostaining in hepatocellular carcinoma.
    Li Y; Liu F; Zhou W; Zhang S; Chu P; Lin F; Wang HL
    Diagn Pathol; 2020 Oct; 15(1):127. PubMed ID: 33054843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
    Chu PG; Ishizawa S; Wu E; Weiss LM
    Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined hepatocellular-cholangiocarcinoma. Diagnostic challenge in hepatic fine needle aspiration biopsy.
    Wee A; Nilsson B
    Acta Cytol; 1999; 43(2):131-8. PubMed ID: 10097699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
    Röcken C; Licht J; Roessner A; Carl-McGrath S
    J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma.
    Johnson DE; Powers CN; Rupp G; Frable WJ
    Mod Pathol; 1992 Mar; 5(2):117-23. PubMed ID: 1374187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions. Can they be distinguished on fine needle aspiration biopsy?
    Wee A; Nilsson B
    Acta Cytol; 2003; 47(1):16-26. PubMed ID: 12585026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material.
    Wong MA; Yazdi HM
    Acta Cytol; 1990; 34(2):192-6. PubMed ID: 2157322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.
    Al-Muhannadi N; Ansari N; Brahmi U; Satir AA
    Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.